MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-22-0024324
Maitreya Lifescience Private Limited
Maitreya Lifescience Private Limited - healthcare in Surat, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.33 Cr
▲ 4% YoY
Net profit · FY 2025
₹2.7 Lakh
Net margin 2%
EBITDA · FY 2025
₹4.69 Lakh
EBITDA margin 3.5%
Authorised capital
₹1.2 Cr
Registered with MCA
Paid-up capital
₹52.46 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Maitreya Lifescience Private Limited
Data last updated:
Maitreya Lifescience Private Limited is a private limited company based in Surat, Gujarat, India, a subsidiary of Maitreya Medicare Limited. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 08 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85320GJ2019PTC108995. Its GSTIN is 24AAMCM7952N1ZQ (Gujarat).
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹52.46 Lakh. It is led by directors including Vimalkumar Natverlal Patel and Narendra Singh Tanwar.
Its last annual general meeting (AGM) was held on 07 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Surat, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.33 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹2.7 Lakh (net margin 2%) and EBITDA of ₹4.69 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 170% over five years.
Maitreya Lifescience Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0024324).
Company details
CIN U85320GJ2019PTC108995
Registration Number 108995
Incorporation Date 08 July 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 07 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Maitreya Medicare Limited
MSME Classification Micro
Udyam Registration UDYAM-GJ-22-0024324
Key People
Vimalkumar Natverlal Patel Director Narendra Singh Tanwar Director Pranav Rohitbhai Thaker Director Recognitions & Rankings of Maitreya Lifescience
Contact details
Maitreya Lifescience Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSai Palace Someshwar Char Rasta, Udhna – Magdalla University Road, Surat, Gujarat, India – 395007
- IndustryHealthcare, Hospitals
To see the full contact details of Maitreya Lifescience Private Limited, buy the company report.
Comprehensive company report
Maitreya Lifescience Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Maitreya Lifescience is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Maitreya Lifescience Private Limited, buy the company report.
Financials of Maitreya Lifescience Private Limited
FY 2025 filings availableMaitreya Lifescience Private Limited reported revenue of ₹1.33 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹1.33 Cr ▲ 4%
Net profit · FY 2025
₹2.7 Lakh margin 2%
EBITDA · FY 2025
₹4.69 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 3%
5 years · compounded
▲ 170%
EBITDA CAGR growth
1 year
▲ 356%
3 years · compounded
▼ 12%
5 years · compounded
▲ 61%
Revenue has grown at a compounded annual rate (CAGR) of 170% over five years, including 4% growth in the latest year. EBITDA rose 356% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maitreya Lifescience Private Limited, buy the company report.
Board of directors of Maitreya Lifescience Private Limited
Maitreya Lifescience has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vimalkumar Natverlal Patel Also directs: Torin Pharmaceuticals Private Limited, Maitreya Hospital Private Limited, Maitreya Medicare Limited and 1 more | Director | 08 Jul 2019 | 7 Years 3 Months | Current |
| Narendra Singh Tanwar Also directs: Torin Pharmaceuticals Private Limited, Maitreya Hospital Private Limited, Maitreya Medicare Limited and 1 more | Director | 08 Jul 2019 | 7 Years 3 Months | Current |
| Pranav Rohitbhai Thaker | Director | 08 Jul 2019 | 7 Years 3 Months | Current |
Peer comparison
Maitreya Lifescience Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Varkha Scans Private Limited | ₹1.33 Cr (FY 2025) | 34.0% | Harda, Madhya Pradesh, India | |||
| Maitreya Lifescience Private Limitedthis company | ₹1.33 Cr (FY 2025) | ₹2.7 Lakh | 2% | 4.0% | Surat, Gujarat, India | |
| A.K, Multi Speciality Hospital Private Limited | ₹1.32 Cr (FY 2025) | 207.0% | Godhra, Gujarat, India | |||
| PNC Techline Private Limited | ₹1.32 Cr (FY 2024) | 269.0% | Punjab, India |
To see the full peer comparison of Maitreya Lifescience Private Limited, buy the company report.
Auditor
Maitreya Lifescience Private Limited is audited by RANA SHAH AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RANA SHAH AND ASSOCIATES | FY 2023 | 126220W |
Shareholding
The shareholding of Maitreya Lifescience Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Maitreya Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maitreya Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maitreya Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maitreya Lifescience has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAMCM7952N1ZQ | Gujarat | Active | 17 Dec 2020 |
To see the full GST registrations and return filing status of Maitreya Lifescience Private Limited, buy the company report.
Recent activity
Maitreya Lifescience Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Suchay Nainesh Parikh ceased to be Director on 20 Jul 2022.
AGM
Maitreya Lifescience Private Limited last Annual general meeting of members was held on 07 Aug 2025 as per latest MCA records.
Filing
Maitreya Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Suchay Nainesh Parikh ceased to be Director.
Ceased
Ranjan Alok ceased to be Director.
Appointed
Narendra Singh Tanwar was appointed as Director.
Appointed
Pranav Rohitbhai Thaker was appointed as Director.
Appointed
Vimalkumar Natverlal Patel was appointed as Director.
Incorporation
08 Jul 2019
Maitreya Lifescience Private Limited was registered on 08 Jul 2019 with Roc Ahmedabad & aged 7 years 3 months as per MCA records.
Frequently asked questions
Maitreya Lifescience is an active private limited company based in Surat, Gujarat, India. The company works in hospitals, within the healthcare industry. It was incorporated on 08 July 2019 (7+ years old) and is registered under CIN U85320GJ2019PTC108995.
Maitreya Lifescience has 3 current directors:
- Vimalkumar Natverlal Patel - Director
- Narendra Singh Tanwar - Director
- Pranav Rohitbhai Thaker - Director
The latest financial statements of Maitreya Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 07 August 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Maitreya Lifescience is 24AAMCM7952N1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Maitreya Lifescience is U85320GJ2019PTC108995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maitreya Lifescience was incorporated on 08 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Maitreya Lifescience by revenue are Varkha Scans Private Limited, A.K, Multi Speciality Hospital Private Limited, PNC Techline Private Limited, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities).
Suchay Nainesh Parikh ceased to be Director on 20 Jul 2022. Ranjan Alok ceased to be Director on 21 Oct 2019. Narendra Singh Tanwar was appointed as Director on 08 Jul 2019. Maitreya Lifescience has 5 board changes on record in total.
Yes, Maitreya Lifescience is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-22-0024324).
The registered office of Maitreya Lifescience is at Sai Palace Someshwar Char Rasta, Udhna – Magdalla University Road, Surat, Gujarat, India – 395007.
Maitreya Lifescience operates in the healthcare industry, in the hospitals segment.